News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,674 Results
Type
Article (8018)
Company Profile (140)
Press Release (476515)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166741)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52874)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238195)
Policy (17898)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (486)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33154)
ALS (105)
Alzheimer's disease (975)
Antibody-drug conjugate (ADC) (263)
Approvals (10375)
Artificial intelligence (320)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (29)
Breast cancer (508)
Cancer (3647)
Cardiovascular disease (217)
Career advice (245)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47867)
Collaboration (1245)
Commercialization (3)
Compensation (1470)
Complete response letters (34)
COVID-19 (754)
CRISPR (63)
C-suite (747)
Cystic fibrosis (85)
Data (5652)
Denatured (4)
Depression (102)
Dermatology (61)
Diabetes (343)
Diagnostics (4186)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (155)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73715)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87613)
Executive appointments (701)
FDA (12388)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (919)
Gene editing (125)
Generative AI (9)
Gene therapy (318)
GLP-1 (290)
Government (942)
Grass and pollen (2)
Guidances (281)
Healthcare (9320)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (157)
Infectious disease (942)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (255)
Interviews (41)
IPO (12387)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (8)
Liver cancer (44)
Longevity (17)
Lung cancer (509)
Lymphoma (250)
Machine learning (27)
Management (3)
Manufacturing (534)
Marketing (8)
MASH (118)
Medical device (8655)
Medtech (8800)
Mergers & acquisitions (14383)
Metabolic disorders (706)
mRNA (55)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (39)
Neuroscience (1824)
NextGen: Class of 2026 (3150)
Non-profit (841)
Obesity (223)
Opinion (10)
Ovarian cancer (158)
Pain (172)
Pancreatic cancer (196)
Parkinson's disease (201)
Partnered (12)
Patents (476)
Patient recruitment (507)
Peanut (31)
People (41236)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15466)
Phase 2 (21375)
Phase 3 (14400)
Pipeline (7324)
Policy (18)
Postmarket research (1570)
Preclinical (6540)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (571)
Real estate (3019)
Recruiting (6)
Regulatory (14818)
Reports (21)
Research institute (581)
Resumes & cover letters (45)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (156)
Series B (121)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (322)
Venture capital (17)
Weight loss (73)
Women's health (79)
Date
Today (10)
Last 7 days (202)
Last 30 days (1545)
Last 365 days (19003)
2026 (12304)
2025 (19251)
2024 (22986)
2023 (26538)
2022 (34588)
2021 (37172)
2020 (33480)
2019 (23275)
2018 (17468)
2017 (18766)
2016 (17917)
2015 (24263)
2014 (21683)
2013 (18138)
2012 (20221)
2011 (20441)
2010 (20332)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (305)
Arkansas (11)
Asia (17889)
Australia (2098)
California (11969)
Canada (3148)
China (524)
Colorado (484)
Connecticut (409)
Delaware (208)
Europe (24629)
Florida (1789)
Georgia (380)
Hawaii (3)
Idaho (46)
Illinois (699)
India (51)
Indiana (314)
Iowa (15)
Japan (399)
Kansas (101)
Kentucky (30)
Louisiana (27)
Maine (26)
Maryland (1202)
Massachusetts (7854)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (116)
New Hampshire (60)
New Jersey (2620)
New Mexico (12)
New York (2822)
North Carolina (1278)
North Dakota (4)
Northern California (5996)
Ohio (278)
Oklahoma (14)
Oregon (16)
Pennsylvania (2253)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4971)
Tennessee (120)
Texas (1940)
United States (38866)
Utah (360)
Vermont (1)
Virginia (153)
Washington D.C. (38)
Washington State (928)
West Virginia (1)
Wisconsin (73)
Wyoming (1)
484,674 Results for "shasqi inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SHASQI STRENGTHENS BOARD OF DIRECTORS WITH THE APPOINTMENT OF FORMER CHIEF DEVELOPMENT OFFICER AT PFIZER ONCOLOGY
October 2, 2025
·
2 min read
Biotech Bay
Shasqi to Present New Data at 2024 World ADC London Conference
Shasqi, Inc. announced that Founder & Chief Executive Officer José M. Mejía Oneto, MD, PhD, will present at the 14th Annual World ADC Conference in London, United Kingdom on Tuesday March 12th at 11:00am GMT.
March 5, 2024
·
2 min read
Biotech Bay
Shasqi to Expand Existing Research Collaboration to Advance Targeted Cancer Treatment
Shasqi, Inc. (“Shasqi”) a clinical stage biotech company whose mission is to make cancer drugs more effective with click chemistry, today announced the expansion of its ongoing research collaboration with Johnson & Johnson Enterprise Innovation Inc.
October 4, 2023
·
2 min read
Biotech Bay
Shasqi Announces Research Collaboration to Transform Targeted Cancer Treatment
Shasqi, Inc. (“Shasqi”), a clinical-stage biotech company, whose mission is to revolutionize cancer treatment with click chemistry, announced today it has entered into a research collaboration with Johnson & Johnson Enterprise Innovation Inc.
June 1, 2023
·
3 min read
Business
Shasqi Expands Board of Directors with Appointment of Biopharma Executives
Shasqi, Inc. a biotech company whose mission is to make cancer drugs more effective with click chemistry, announced the expansion of its board with the appointment of Pamela M. Klein, M.D., and Mark McCamish M.D., Ph.D.
January 4, 2024
·
2 min read
Biotech Bay
Shasqi to Present Data on Novel Tumor-Targeted Drug Activation Technology at 2024 American Association for Cancer Research (AACR) Annual Meeting
Shasqi, Inc. today announced it will present five posters on the company’s novel tumor-targeted drug activation approach at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, April 5-10, 2024.
April 5, 2024
·
3 min read
Business
Shasqi Appoints Oncology Luminaries to its Inaugural Scientific Advisory Board, Alongside the Expansion of its Leadership Team
Shasqi, Inc. announced the formation of its Scientific Advisory Board composed of leaders with decades of experience in oncology drug development and translational research.
August 2, 2023
·
6 min read
Biotech Bay
Shasqi Publishes Data on Systemic Antigen Targeting Approach, Using Click Chemistry to Activate MMAE in Tumors
Shasqi, Inc. announced the expansion of its Click Activated Protodrugs Against Cancer platform with a pivotal manuscript describing the preclinical development of SQ2201, a novel cancer therapy.
June 28, 2023
·
3 min read
Drug Development
Shasqi Advances SQ3370 to Phase 2 in Solid Tumors
Shasqi announced it has opened the Phase 2 of their Phase 1/2a clinical study to further assess SQ3370 in anthracycline- naïve patients.
September 12, 2022
·
4 min read
Business
Shasqi Scientific Advisor Carolyn Bertozzi Awarded Nobel Prize for the Development of Click Chemistry
Shasqi announced that the company’s scientific advisor, Carolyn Bertozzi, Ph.D., has been awarded the 2022 Nobel Prize in Chemistry, alongside Morten Meldal, Ph.D., and Nobel Laureate K. Barry Sharpless, Ph.D., for the development of click chemistry and bioorthogonal chemistry.
October 6, 2022
·
3 min read
1 of 48,468
Next
